We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Civica Rx — the nonprofit drug company created by hospital groups to help deal with high generic drug prices and shortages — announced on Monday that it’s on track to launch more than 14 hospital-administered generic drugs this year and has added 12 new member groups representing 250 hospitals. Read More
The FDA will run out of funds for PDUFA reviews in “about one month,” FDA Commissioner Scott Gottlieb tweeted as the federal shutdown entered its third week. Read More
“We are pleased to have reached this settlement and will continue to defend our innovative medicines against any challenge,” said Neos CEO Jerry McLaughlin. Read More
A motion by a group of generic drugmakers for a gag order against the states suing them for price-fixing would be unwarranted and unconstitutional, the attorneys general said in a filing last week. Read More
The UK’s Medicines and Healthcare products Regulatory Agency released new details of how it plans to continue drug regulatory operations if there is no Brexit deal by March 29 — including new fees to cover its added regulatory burden. Read More
The Medicare Payment Advisory Committee (MedPAC), an independent congressional agency, joined critics of the HHS proposal to link Medicare Part B drug pricing to prices in other countries. Read More
The CMS proposal to require the disclosure of drug prices in TV ads is getting pushback from major drug manufacturers who claim the list prices would confuse consumers. Read More
Drugmakers hiked the price of more than 250 drugs on January 1 — compared to more than 400 at this time last year, according to data from price tracking firm Rx Savings Solutions. Read More